{"id":"https://openalex.org/W2009703085","doi":"https://doi.org/10.1002/cncr.20859","title":"A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first\u2010line treatment in patients with poor\u2010prognosis small cell lung carcinoma","display_name":"A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first\u2010line treatment in patients with poor\u2010prognosis small cell lung carcinoma","publication_year":2005,"publication_date":"2005-01-07","ids":{"openalex":"https://openalex.org/W2009703085","doi":"https://doi.org/10.1002/cncr.20859","mag":"2009703085","pmid":"https://pubmed.ncbi.nlm.nih.gov/15641037"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.20859","doi":"https://doi.org/10.1002/cncr.20859","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.20859","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.20859","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.20859","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003664573","display_name":"Filippo de Marinis","orcid":"https://orcid.org/0000-0002-1118-5536","observed_orcids":["https://orcid.org/0000-0002-1118-5536"]},"institutions":[{"id":"https://openalex.org/I4210095143","display_name":"Azienda Ospedaliera San Camillo-Forlanini","ror":"https://ror.org/00j707644","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210095143"]},{"id":"https://openalex.org/I4210153088","display_name":"Carlo Forlanini Hospital","ror":"https://ror.org/04z5vy146","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153088"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Filippo De Marinis","raw_affiliation_strings":["Fifth Operative Unit of Pulmonary Oncology, Carlo Forlanini Hospital, Rome, Italy. f.demarinis@oncpneumo.it","Fifth Operative Unit of Pulmonary Oncology, Carlo Forlanini Hospital, Rome, Italy","Foundation for Oncological Research, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fifth Operative Unit of Pulmonary Oncology, Carlo Forlanini Hospital, Rome, Italy. f.demarinis@oncpneumo.it","institution_ids":["https://openalex.org/I4210095143","https://openalex.org/I4210153088"]},{"raw_affiliation_string":"Fifth Operative Unit of Pulmonary Oncology, Carlo Forlanini Hospital, Rome, Italy","institution_ids":["https://openalex.org/I4210095143","https://openalex.org/I4210153088"]},{"raw_affiliation_string":"Foundation for Oncological Research, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020421670","display_name":"Fabrizio Nelli","orcid":"https://orcid.org/0000-0001-8374-1362","observed_orcids":["https://orcid.org/0000-0001-8374-1362"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabrizio Nelli","raw_affiliation_strings":["La Sapienza University, Medical Oncology, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"La Sapienza University, Medical Oncology, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marco Lombardo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Lombardo","raw_affiliation_strings":["Santo Spirito Hospital, Medical Oncology, Pescara, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Santo Spirito Hospital, Medical Oncology, Pescara, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048720703","display_name":"Francesco Ferra\u00f9","orcid":"https://orcid.org/0000-0002-7472-6598","observed_orcids":["https://orcid.org/0000-0002-7472-6598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Ferra\u00fa","raw_affiliation_strings":["San Vincenzo Hospital, Medical Oncology, Taormina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Vincenzo Hospital, Medical Oncology, Taormina, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108527227","display_name":"Santi Barbera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102769","display_name":"Azienda Ospedaliera di Cosenza","ror":"https://ror.org/01884b046","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210102769"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Santi Barbera","raw_affiliation_strings":["Mariano Santo Hospital, Medical Oncology, Cosenza, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mariano Santo Hospital, Medical Oncology, Cosenza, Italy","institution_ids":["https://openalex.org/I4210102769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020736353","display_name":"Oscar Bertetto","orcid":"https://orcid.org/0000-0001-5133-2724","observed_orcids":["https://orcid.org/0000-0001-5133-2724"]},"institutions":[{"id":"https://openalex.org/I4210096532","display_name":"Fondazione Ricerca Molinette","ror":"https://ror.org/01mhzrb93","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210096532"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Oscar Bertetto","raw_affiliation_strings":["Molinette Hospital, Medical Oncology, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molinette Hospital, Medical Oncology, Turin, Italy","institution_ids":["https://openalex.org/I4210096532"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061179981","display_name":"Sandro Barni","orcid":"https://orcid.org/0000-0002-7633-0378","observed_orcids":["https://orcid.org/0000-0002-7633-0378"]},"institutions":[{"id":"https://openalex.org/I4210161395","display_name":"Azienda Ospedaliera Treviglio","ror":"https://ror.org/05rv6z116","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210161395"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sandro Barni","raw_affiliation_strings":["Treviglio-Caravaggio Hospital, Medical Oncology, Treviglio, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Treviglio-Caravaggio Hospital, Medical Oncology, Treviglio, Italy","institution_ids":["https://openalex.org/I4210161395"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049781283","display_name":"G. Michetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovanni Michetti","raw_affiliation_strings":["Riuniti Hospital, Pulmonary Disease Unit, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riuniti Hospital, Pulmonary Disease Unit, Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084773667","display_name":"Roberto Labianca","orcid":"https://orcid.org/0000-0001-7149-822X","observed_orcids":["https://orcid.org/0000-0001-7149-822X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roberto Labianca","raw_affiliation_strings":["Riuniti Hospital, Medical Oncology, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riuniti Hospital, Medical Oncology, Bergamo, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045384053","display_name":"Cesare Gridelli","orcid":"https://orcid.org/0000-0003-1069-597X","observed_orcids":["https://orcid.org/0000-0003-1069-597X"]},"institutions":[{"id":"https://openalex.org/I4210111929","display_name":"Azienda Ospedaliera S.Giuseppe Moscati","ror":"https://ror.org/021jxzw96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210111929"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cesare Gridelli","raw_affiliation_strings":["Moscati Hospital, Medical Oncology, Avellino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moscati Hospital, Medical Oncology, Avellino, Italy","institution_ids":["https://openalex.org/I4210111929"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5003664573"],"corresponding_institution_ids":["https://openalex.org/I4210095143","https://openalex.org/I4210153088"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.2435,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.78675872,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"103","issue":"4","first_page":"772","last_page":"779"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9860000014305115},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/poor-prognosis","display_name":"poor prognosis","score":0.7749999761581421},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7689999938011169},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8349999785423279},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.5239999890327454},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9232771396636963},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8771054744720459},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7961211204528809},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7446503639221191},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6175585985183716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6124744415283203},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5826983451843262},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5734890103340149},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5419330596923828},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5104633569717407},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4648323059082031},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43277519941329956},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4090147018432617}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018288","descriptor_name":"Carcinoma, Small Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018288","descriptor_name":"Carcinoma, Small Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.20859","doi":"https://doi.org/10.1002/cncr.20859","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.20859","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.20859","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:15641037","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15641037","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1002/cncr.20859","doi":"https://doi.org/10.1002/cncr.20859","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.20859","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.20859","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2009703085.pdf","grobid_xml":"https://content.openalex.org/works/W2009703085.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W4434567","https://openalex.org/W1979300931","https://openalex.org/W1994351520","https://openalex.org/W2000159952","https://openalex.org/W2007526924","https://openalex.org/W2029409133","https://openalex.org/W2047930003","https://openalex.org/W2060171352","https://openalex.org/W2073683299","https://openalex.org/W2086905049","https://openalex.org/W2105847144","https://openalex.org/W2111218876","https://openalex.org/W2127776375","https://openalex.org/W2128076724","https://openalex.org/W2130164889","https://openalex.org/W2133495180","https://openalex.org/W2139184637","https://openalex.org/W2167805334","https://openalex.org/W2168980896","https://openalex.org/W2173643829","https://openalex.org/W2268190867","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2086905049","https://openalex.org/W2008309443","https://openalex.org/W2105847144","https://openalex.org/W1975100056","https://openalex.org/W1983711716","https://openalex.org/W2073426637","https://openalex.org/W2167050057","https://openalex.org/W4243664419","https://openalex.org/W2010794129","https://openalex.org/W2105544590"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,124,202],"objective":[2,125],"of":[3,13,106,111,116,146,214,222,243],"this":[4,244],"study":[5],"was":[6,128,205],"to":[7,50,163,240],"evaluate":[8],"the":[9,144,153,169,176,187,194,235,241,249,263],"activity":[10],"and":[11,17,20,32,65,72,88,108,137,157,172,179,190,218,225],"toxicity":[12,211,260],"combined":[14,21],"cisplatin,":[15],"etoposide,":[16],"gemcitabine":[18,24,66,82],"(PEG)":[19],"cisplatin":[22,53,75],"plus":[23,81],"(PG)":[25],"in":[26,45,121,152,168,175,186,193,199,212,266],"previously":[27],"untreated":[28],"patients":[29,42,44,267],"with":[30,113,143,207,262,268],"extensive-stage":[31,269],"poor-prognosis":[33],"limited-stage":[34,272],"small-cell":[35],"lung":[36,275],"carcinoma.":[37,276],"METHODS:":[38],"One":[39],"hundred":[40],"forty":[41],"(70":[43],"two":[46,236],"arms)":[47],"were":[48,92,102,197],"randomized":[49,247],"receive":[51],"either":[52],"70":[54,76],"mg/m2":[55,61,68,77,84],"on":[56,62,69,78,85],"Day":[57,79],"1,":[58],"etoposide":[59],"50":[60],"Days":[63,70,86],"1-3,":[64],"1000":[67],"1":[71,80,87],"8":[73],"or":[74,270],"1250":[83],"8.":[89],"Both":[90],"regimens":[91],"recycled":[93],"every":[94],"21":[95],"days.":[96],"RESULTS:":[97],"In":[98],"total,":[99],"626":[100],"cycles":[101,105,110,118],"delivered":[103],"(303":[104],"PEG":[107,136,154,170,188,203,250],"323":[109],"PG),":[112],"a":[114,147,180,219,253],"median":[115,182],"4":[117],"per":[119],"patient":[120],"both":[122,200],"arms.":[123,201,237],"response":[126,150,256],"rate":[127,151,221,257],"63%":[129],"(95%":[130],"confidence":[131],"interval":[132],"[95%CI],":[133],"49-71%)":[134],"for":[135,141],"57%":[138],"(95%CI,":[139],"43-67%)":[140],"PG,":[142],"suggestion":[145],"higher":[148,220,254],"complete":[149,255],"arm":[155,171,189],"(18.6%":[156],"4.3%,":[158],"respectively).":[159],"A":[160],"similar":[161,181],"time":[162],"disease":[164],"progression":[165],"(6":[166],"months":[167,174,185,192],"7":[173],"PG":[177,195,264],"arm)":[178,196],"survival":[183],"(9.5":[184],"10":[191],"observed":[198],"regimen":[204,251,265],"associated":[206],"more":[208,259],"severe":[209],"hematologic":[210],"terms":[213],"neutropenia,":[215,217],"febrile":[216],"treatment":[223],"delays":[224],"dose":[226],"reductions,":[227],"whereas":[228],"nonhematologic":[229],"toxicities":[230],"did":[231],"not":[232],"differ":[233],"between":[234],"CONCLUSIONS:":[238],"According":[239],"results":[242],"Phase":[245],"II":[246],"trial,":[248],"produced":[252],"but":[258],"compared":[261],"poor-prognosis,":[271],"small":[273],"cell":[274]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}